Gene · 1445
Papers4,278
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
261 to 280 of 4,278
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Inducer-free recombinant protein production in Trichoderma reesei: secretory production of endogenous enzymes and heterologous nanobodies using glucose as the sole carbon source. | Microb Cell Fact | 2023 | 37208691 | PubTator, text mining | PubMed |
| Phosphatase regenerating liver 3 participates in Integrinβ1/FAK-Src/MAPK signaling pathway and contributes to the regulation of malignant behaviors in hepatocellular carcinoma cells. | J Gastrointest Oncol | 2023 | 37201051 | PubTator, text mining | PubMed |
| Discovery of Novel Bruton's Tyrosine Kinase PROTACs with Enhanced Selectivity and Cellular Efficacy. | J Med Chem | 2023 | 37195170 | PubTator, text mining | PubMed |
| Role and mechanistic actions of protein kinase inhibitors as an effective drug target for cancer and COVID. | Arch Microbiol | 2023 | 37193831 | PubTator, text mining | PubMed |
| Identification and validation of biomarkers based on cellular senescence in mild cognitive impairment. | Front Aging Neurosci | 2023 | 37187578 | PubTator, text mining | PubMed |
| Protein Tyrosine Phosphatase Receptor Zeta 1 as a Potential Target in Cancer Therapy and Diagnosis. | Int J Mol Sci | 2023 | 37175798 | PubTator, text mining | PubMed |
| Distinct Traits of Structural and Regulatory Evolutional Conservation of Human Genes with Specific Focus on Major Cancer Molecular Pathways. | Cells | 2023 | 37174700 | PubTator, text mining | PubMed |
| CRISPR-Cas9 screen reveals a role of purine synthesis for estrogen receptor α activity and tamoxifen resistance of breast cancer cells. | Sci Adv | 2023 | 37172090 | PubTator, text mining | PubMed |
| The Src-ZNRF1 axis controls TLR3 trafficking and interferon responses to limit lung barrier damage. | J Exp Med | 2023 | 37158982 | PubTator, text mining | PubMed |
| The c-Src/LIST Positive Feedback Loop Sustains Tumor Progression and Chemoresistance. | Adv Sci (Weinh) | 2023 | 37156751 | PubTator, text mining | PubMed |
| Progesterone and its metabolite allopregnanolone promote invasion of human glioblastoma cells through metalloproteinase‑9 and cSrc kinase. | Oncol Lett | 2023 | 37153033 | PubTator, text mining | PubMed |
| Dasatinib targets c-Src kinase in cardiotoxicity. | Toxicol Rep | 2023 | 37152411 | PubTator, text mining | PubMed |
| Acute inflammatory reaction during anti-angiogenesis therapy combined with immunotherapy as a possible indicator of the therapeutic effect: Three case reports and literature review. | Front Oncol | 2023 | 37124541 | PubTator, text mining | PubMed |
| A review of signal pathway induced by virulent protein CagA of Helicobacter pylori. | Front Cell Infect Microbiol | 2023 | 37124036 | PubTator, text mining | PubMed |
| Functional roles of SRC signaling in pancreatic cancer: Recent insights provide novel therapeutic opportunities. | Oncogene | 2023 | 37120696 | PubTator, text mining | PubMed |
| The Efficacy and Safety of 'Inverted Omega En-bloc' Holmium Laser Enucleation of the Prostate (HoLEP) for Benign Prostatic Hyperplasia: A Size-Independent Technique for the Surgical Treatment of LUTS. | World J Mens Health | 2023 | 37118958 | PubTator, text mining | PubMed |
| The Envelope (E) Protein of SARS-CoV-2 as a Pharmacological Target. | Viruses | 2023 | 37112980 | PubTator, text mining | PubMed |
| MERS-CoV seroconversion amongst Malaysian Hajj pilgrims returning from the Middle East, 2016-2018: results from the MERCURIAL multiyear prospective cohort study. | Emerg Microbes Infect | 2023 | 37101375 | PubTator, text mining | PubMed |
Cell Entry of Avian Reovirus Modulated by Cell-Surface Annexin A2 and Adhesion G Protein-Coupled Receptor Latrophilin-2 Triggers Src and p38 MAPK Signaling Enhancing Caveolin-1- and Dynamin 2-Dependent Endocytosis. | Microbiol Spectr | 2023 | 37097149 | PubTator, text mining | PubMed |
| Preclinical pharmacokinetic and pharmacodynamic evaluation of dasatinib and ponatinib for the treatment of T-cell acute lymphoblastic leukemia. | Leukemia | 2023 | 37076694 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/1445/papers?page=14